In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1853 News Items found
A presentation stage at the San Antonio Breast Cancer Symposium.
In the News
Updates from SABCS 2019: Detection and Screening, Immunotherapy Advances, and Therapy Resistance

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.
MSK’S Facilities Management Team Create 26th Annual Holiday Hallway at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition. 
Memorial Sloan Kettering medical oncologist Eileen O’Reilly
In the News
Year in Review: 10 Important Clinical Research Discoveries in 2019

As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.
Illustration of breast cancer cell
In the Clinic
Targeted Drug Shows Promise Against HER2-Positive Breast Cancer That Stops Responding to Other Drugs

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
Innovative Research and Comprehensive Clinical Care at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.
State-of-the-Art Structural Resiliency and Environmental Sustainability at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center

The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility.
Micrograph of multiple myeloma cells
In the News
MSK Experts Report New Findings about Multiple Myeloma at the 2019 ASH Meeting

Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.
Exterior shot of building at ASH meeting
In the News
MSK Experts Report Advances in Lymphoma Treatment at the 2019 ASH Meeting

Learn more about the work of MSK lymphoma researchers being presented at the 2019 meeting of the American Society of Hematology.
MSK’s Largest Freestanding Patient Care Facility Prepares to Open

After years of planning and anticipation, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is scheduled to open in January 2020.
MSK patient playing with child life therapist
Feature
How Medical Play Helps Children Feel Empowered at MSK Kids

Discover how MSK Kids is using medical play to help children understand treatments and procedures.